Related Experiment Video
Updated: Aug 31, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
Eco-Evolutionary Dynamics of Proliferation Heterogeneity: A Phenotype-Structured Model for Tumor Growth and Treatment
Lara Schmalenstroer1, Haojun Chen2, Russell C Rockne3
1Bioinformatics and Computational Biophysics, University of Duisburg-Essen, Duisburg-Essen, Germany.
Abstract:
Intra-tumor heterogeneity in proliferation rates fundamentally influences cancer progression and treatment resistance. To investigate how continuous phenotypic variation shapes eco-evolutionary dynamics, we develop a phenotype-structured partial differential equation framework that explicitly models proliferation heterogeneity as a dynamic trait. Our model integrates three key biological principles: (1) phenotypic diffusion capturing heritable variation in proliferation rates, (2) global resource competition enforcing density-dependent growth constraints, and (3) an experimentally grounded life-history trade-off linking elevated proliferation to increased mortality. Using adaptive dynamics, we derive the optimum proliferation rate in a growing tumor, showing that the optimal phenotype dynamically shifts toward slower proliferation as tumors approach carrying capacity under control condition. We perform in silico treatment simulations for four different treatment regimes (uniform targeting, low-, mid-, and high-proliferation targeting) to show how therapeutic selective pressures reshape fitness landscapes. While all treatments slow down tumor growth, they induce divergent evolutionary trajectories. We connect these dynamics with changes in mean proliferation rates during and after treatment. Our work establishes a predictive, evolutionarily grounded framework for understanding how therapy reshapes tumor proliferation landscapes, offering a mechanistic basis for designing strategies that anticipate and counteract adaptive resistance.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

